{"id":"W3003334583","doi":"10.1111/bjd.18898","title":"Baricitinib in patients with moderate‐to‐severe atopic dermatitis and inadequate response to topical corticosteroids: results from two randomized monotherapy phase<scp>III</scp>trials","year":2020,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":379,"is_retracted":false,"has_abstract":true,"ca_institutions":"Innovaderm (Canada)","funders":"Lundbeckfonden; Eli Lilly and Company","keywords":"Medicine; Placebo; Atopic dermatitis; Concomitant; Adverse effect; Randomized controlled trial; Internal medicine; Gastroenterology; Clinical endpoint; Erythema; Phases of clinical research; Clinical trial; Dermatology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005041662,0.00024882,0.002230723,0.000239781,0.00007991786,0.0000825548,0.0001764323,0.0001830761,0.00002245071],"category_scores_gemma":[0.007711977,0.0002255592,0.0001685012,0.0002394702,0.0001562764,0.0002012036,0.00005962225,0.0004381859,0.00001268402],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003753797,"about_ca_system_score_gemma":0.0002043879,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00008331295,"about_ca_topic_score_gemma":0.00004661,"domain_scores_codex":[0.995254,0.001833449,0.001842513,0.0003533353,0.0003321816,0.0003845624],"domain_scores_gemma":[0.9952347,0.003093987,0.0005481492,0.0001653714,0.0002782278,0.00067959],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7579674,0.001066615,0.13463,0.00009956547,0.001128649,0.03108088,0.006272407,0.000116005,0.0002014919,0.00003171621,0.02873649,0.03866872],"study_design_scores_gemma":[0.7434934,0.0008877994,0.2372487,0.0008499856,0.0003799019,0.01203862,0.0003061182,0.0004340429,0.001534398,0.0004038298,0.00220671,0.0002164528],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9810693,0.001630258,0.002116863,0.01376236,0.0001401754,0.001061872,0.0001337324,0.00002391357,0.00006158566],"genre_scores_gemma":[0.986567,0.0002426738,0.001438807,0.01154653,0.00009563726,0.00002478768,0.00004086892,0.0000270979,0.00001660523],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1026187,"threshold_uncertainty_score":0.9232513,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01951308054702021,"score_gpt":0.2875085191582279,"score_spread":0.2679954386112077,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}